Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04585555 · ClinicalTrials.gov registry record
Physiologic Signals and Signatures With the Accuryn Monitoring System (The Accuryn Registry)
A clinical trial, sponsored by Potrero Medical.
- Completed
- Registry status
- 50
- Enrollment target
NCT04585555: Completed study, sponsored by Potrero Medical.
NCT04585555 is a clinical trial that has completed, run by Potrero Medical. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04585555 has completed, sponsored by Potrero Medical.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.
Primary Outcome
High accuracy Urine Output (mL/hour) while on a urinary catheter, and estimated UO while not on a urinary catheter
Interventions
- DEVICE Accuryn Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2019-11-05 |
What the finished NCT04585555 record still lists
NCT04585555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Accuryn Monitoring System is the first listed.
NCT04585555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04585555 about?
NCT04585555 is a clinical study titled "Physiologic Signals and Signatures With the Accuryn Monitoring System (The Accuryn Registry)". The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using elect...
What is the current status of trial NCT04585555?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-07-10. Estimated completion is 2019-11-05.
What interventions are being tested in trial NCT04585555?
The interventions under investigation include: Accuryn Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT04585555?
This trial is sponsored by Potrero Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI